Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

DR. ADAM´S ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   3.6% 3.6% 3.6% 3.6% 3.6% 3.6% 3.6% 3.6%   Bankruptcy risk   1.1% 0.9% 0.7% 0.6% 0.6% 0.7% 7.3% 7.1%   Credit score (0-100)   85 89 94 96 96 94 33 34   Credit rating   A A AA AA AA AA BBB BBB   Credit limit (kDKK)   287.2 643.7 1,144.1 1,330.1 1,398.5 1,228.6 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   4,516 5,015 6,065 7,151 7,670 6,628 0.0 0.0   EBITDA   658 965 2,011 2,239 2,868 1,379 0.0 0.0   EBIT   493 798 1,855 2,082 2,696 1,225 0.0 0.0   Pre-tax profit (PTP)   379.4 679.9 1,569.6 1,888.1 2,319.2 1,164.6 0.0 0.0   Net earnings   291.6 525.8 1,221.8 1,473.1 1,811.6 905.7 0.0 0.0   Pre-tax profit without non-rec. items   379 680 1,570 1,888 2,319 1,165 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   5,461 5,293 5,136 5,104 4,932 4,856 0.0 0.0   Shareholders equity total   6,637 7,163 8,385 9,358 10,169 10,075 9,375 9,375   Interest-bearing liabilities   3,661 3,165 2,870 1,784 2,620 3,100 0.0 0.0   Balance sheet total (assets)   14,989 14,698 16,802 17,712 18,107 18,821 9,375 9,375   Net Debt   2,215 1,255 -1,494 -2,717 -1,082 701 -9,375 -9,375     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   4,516 5,015 6,065 7,151 7,670 6,628 0.0 0.0   Gross profit growth   -0.4% 11.0% 20.9% 17.9% 7.3% -13.6% -100.0% 0.0%   Employees   12 12 11 11 13 14 0 0   Employee growth %   20.0% 0.0% -8.3% 0.0% 18.2% 7.7% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   14,989 14,698 16,802 17,712 18,107 18,821 9,375 9,375   Balance sheet change%   4.0% -1.9% 14.3% 5.4% 2.2% 3.9% -50.2% 0.0%   Added value   658.1 965.4 2,011.3 2,238.6 2,851.7 1,378.5 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -234 -335 -313 -188 -344 -230 -4,856 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   10.9% 15.9% 30.6% 29.1% 35.1% 18.5% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   3.4% 5.4% 11.8% 12.1% 15.1% 7.0% 0.0% 0.0%   ROI %   4.6% 7.4% 16.5% 17.8% 21.6% 9.6% 0.0% 0.0%   ROE %   4.3% 7.6% 15.7% 16.6% 18.6% 8.9% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   44.3% 48.7% 49.9% 52.8% 56.2% 53.5% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   336.6% 130.0% -74.3% -121.4% -37.7% 50.9% 0.0% 0.0%   Gearing %   55.2% 44.2% 34.2% 19.1% 25.8% 30.8% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   3.1% 3.5% 9.4% 8.4% 17.1% 4.4% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.4 0.4 0.8 0.7 0.7 0.5 0.0 0.0   Current Ratio   1.5 1.6 1.7 1.8 1.9 1.8 0.0 0.0   Cash and cash equivalent   1,445.7 1,909.8 4,363.5 4,501.4 3,702.8 2,398.9 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   2,993.3 3,561.4 4,789.1 5,443.6 6,191.6 5,937.2 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   55 80 183 204 219 98 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   55 80 183 204 221 98 0 0   EBIT / employee   41 66 169 189 207 88 0 0   Net earnings / employee   24 44 111 134 139 65 0 0